DocWire News Editors

DocwireNews

Patients undergoing percutaneous coronary intervention (PCI) are at risk for acute kidney injury (AKI). There are few available data quantifying racial differences in the incidence of AKI following PCI. Joseph Lunyera, MBChB, and colleagues conducted an analysis to examine the association between self-reported race and baseline estimated glomerular filtration rate (eGFR) with the incidence of AKI at a single center between January 1, 2003, and December 31, 2013.Results of the analysis were reported during a virtual poster session at ASN Kidney Week 2020. The poster was titled Racial Differences in AKI Following Percutaneous Coronary Intervention.Patients who underwent PCI at Duke University School of Medicine, Durham, North Carolina, self-reported their race as Black, White, or other. Data were gathered in the Duke Databank for Cardiovascular Disease. AKI was defined as &ge;1.5-fold increase in serum creatinine from outpatient reference value prior to PCI to the peak value within 7 days following PCI or a 0.3 mg/dL increase from the reference value within 48 hours.The researchers utilized logistic regression adjusted for demographics, comorbidities, predisposing medications (nonsteroidal anti-inflammatory drugs, renin-angiotensin-aldosterone system inhibitors, diuretics), PCI indication (presenting with vs without acute coronary syndrome), peri-procedural prophylaxis with intravenous fluids and n-acetylcysteine, urgency of PCI, and blood pressure at the time of PCI.The cohort included 9422 patients; median age was 63 years, 33% were female, 75% were White, 20% were Black, and 5% were other race. Nine percent of the total cohort developed AKI: 14% of Blacks, 8% of Whites, and 10% in other race groups.Following adjustment, there was an association between Black race and greater likelihood of AKI: odds ratio (OR), in Black (vs White) patients, was 1.80 (95% confidence interval [CI], 1.49-2.18). Compared with White patients, there was no association between AKI and other race (OR, 1.31; 95% CI, 0.91-1.87). There was an association between low baseline eGFR and graded, higher likelihood of AKI: P for trend &lt;.001. There was no interaction between race and baseline eGFR.&ldquo;Black patients had nearly twice the likelihood for AKI following PCI than Whites despite adjustment for baseline kidney function, prophylaxis, and procedural characteristics. Future investigations should identify other factors that predispose Black individuals to disparate AKI risk following PCI,&rdquo; the researchers said.Read more here: <a href="https://www.asn-online.org/education/kidneyweek/2020/program-abstract.aspx?controlId=3445284">https://www.asn-online.org/education/kidneyweek/2020/program-abstract.aspx?controlId=3445284</a>Source: Lunyera J, Clare RM, Chiswell K, et al. Racial differences in AKI following percutaneous coronary intervention. Abstract of a poster presented at the American Society of Nephrology virtual Kidney Week 2020 (PO0017), October 22, 2020.

Meghan Sise, MD

Joel M. Topf, MD, FACP

Redefining Carboplatin Dosing

NKF Spring Clinical Meetings 2025

MarkAlain Déry, DO

The Significant Danger Measles Pose for Unvaccinated Children

Infectious Disease

Andrew Moreno

Antithrombotic Care in Hemophilia: A Summary of Multi-Organizational Clinical Practice Guidance

Hemophilia

Latest News

Racial Disparity in Likelihood of AKI Following PCI

ASN Kidney Week 2020

Patients undergoing percutaneous coronary intervention (PCI) are at risk for acute kidney injury (AKI). There are few available data quantifying racial differences in the ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe